Over a year ago, your philanthropic support helped jumpstart Drug Innovation Ventures at Emory’s (DRIVE) work on an investigational oral antiviral therapeutic for coronavirus. Now called Molnupiravir, Merck and Ridgeback announced their plan to seek Emergency Use Authorization (EUA) for Molnupiravir on October 1, 2021.

Dr. Jonathan S. Lewin, Executive Vice President for Health Affairs at Emory University and CEO and Chair of the Board of Emory Healthcare shared, “this is a true breakthrough in the international fight against COVID-19, and our team at DRIVE deserves great credit for their work in bringing this drug to fruition. Congratulations to the DRIVE team and to all the Emory researchers whose work has contributed and led up to this important discovery. It is a wonderful example of the importance of academic research that improves lives and brings hope to millions.” 

Join us today, Wednesday, Oct. 6th at 11 am EDT, for a Facebook LIVE event with Emory University President Gregory L. Fenves and Emory's Dr. Jodie Guest to discuss Molnupiravir within the larger context of Emory's research eminence. Emory has in the past advanced the development of some of the world’s most important and valuable antiviral drugs, successfully taking treatments from bench to bedside. https://www.facebook.com/events/283208183445876?ref=newsfeed

Again thank you for your support in the fight against COVID-19. You can find more information on Molnupiravir at these sites.

https://news.emory.edu/stories/2021/10/eua_application_expected_for_molnupiravir_covid_19/index.html

https://news.emory.edu/tags/topic/molnupiravir/index.html

Thanks to you—Emory’s #GivingTuesdayNow campaign was a great success. The homepage will continue to tell the story! Check momentum.emory.edu to see the total number of donors, which shows the ever-increasing strength and generosity of our community.

Thanks to you—Emory will continue to help members of our community and advance life-saving research. By standing together with thousands of other donors, you are helping fight this pandemic.  

Thanks to you—Emory continues to deliver more than 9,000 meals a week to keep frontline health care heroes energized and fed. We’ve delivered more than 40,000 meals in Atlanta to date.

Thanks to you—Emory is making progress in the fight to end COVID-19. This recent news about Emory’s remdesivir trial—has been hailed by Anthony Fauci, MD, the director of the National Institute of Allergy and Infectious Diseases (NIAID) as a gamechanger in the quest for new treatment.

Your gift is helping fund the way forward.

Emory thanks you.

You are part of Emory’s efforts in leading the fight against COVID-19. #GivingTuesdayNow is a new global day of giving and unity that will take place on May 5 as an emergency response to the unprecedented need caused by the novel coronavirus.

You have already contributed to DRIVE to end COVID-19 (THANK YOU!) so now we ask you to take the next step of amplifying your impact. Energize your family, friends, and colleagues via email, text, or social media—or give them a call—inviting them to join you in taking an active step to fight the pandemic.

Two ways you can help:

1. Use the GivingTuesdayNow social toolkit for messaging suggestions and images.

2. Sign up as a volunteer fundraising ambassador. You will have a personalized link to track who makes a gift as a result of your efforts. Your ambassador dashboard also gives you access to additional peer-to-peer messaging ideas and images.

Use the links below to sign up as a fundraising ambassador for the causes you care about:

DRIVE to end COVID-19- supporting Drug Innovation Ventures at Emory’s research for a coronavirus cure

Feed the Frontline- providing meals to our frontline health care workers in Atlanta

Emory COVID-19 Impact Fund- supporting Emory’s health care research and patient needs

Healthcare Employee Hardship Fund- providing financial assistance for Emory Healthcare employees

Public Health Preparedness and Research Fund-  supporting research for pandemic preparedness

Emory Together Fund- supporting emergency relief for Emory University students, faculty, and staff

By promoting #GivingTuesdayNow and #EmoryTogether, you are helping to fight the pandemic. Thank you!

Your gift to DRIVE is already at work, fueling the innovations behind a potential treatment for COVID-19. Around Emory, others are joining you in this effort, banding together to support DRIVE’s initiatives.

The Emory University Department of Music is hosting a fundraising concert benefiting DRIVE. Emory Piano students will present a livestream performance on Facebook today, Friday, April 17 from 10:30 a.m.-12:30 p.m. EST.

As a valued donor, we invite you to join this virtual concert, and we hope you will amplify this opportunity by sharing it with your network.

The collective efforts of our community are more important than ever. Thank you for leading our efforts.

Thank you for your gift to benefit Drug Innovation Ventures at Emory (DRIVE) through the #EndPandemicsNow campaign.

In order to showcase this project alongside Emory’s greater COVID-19 response, we have moved the campaign to Momentum—Emory’s crowdfunding platform—under the title, “DRIVE to end COVID-19.”

Moving forward, you will receive Momentum updates (like this) about DRIVE’s progress during this time of rapidly changing developments. While you are welcome to unsubscribe at any time, we intend to keep you informed about the impact of your gift throughout this campaign.

You are also invited to increase the impact of your gift and to advance the “DRIVE to end COVID-19” by sharing on Facebook, Twitter, and LinkedIn.

Thanks again for supporting DRIVE’s effort to end deadly pandemics and outbreaks caused by viruses like the novel coronavirus.

We couldn’t do it without your help.